PROGRAM

Thursday 9th October 2025

0900 - 1215   
Workshop 1 - The Power of AI in Medicine & How to Get Started
Lindsay Page & Laura Hatton
Daniel de Viana
0900 - 1215
Workshop 2 - Updates in Radiation Oncology 
Topics
  • Fractionation and breast radiotherapy – What is the expert view on standard of care 2025?
  • Oncoplastic surgery – What are the radiotherapy implications for conserving surgery and mastectomy?
  • Volume delineation for breast radiotherapy - focus on partial breast and reconstructions (implants and tissue based)
  • Volume delineation  -potentials and pitfalls 
  • Treatment planning and delivery  
Orit Kaidar-Person
0900 - 1215
Workshop 3 - Mastering Perforator Flaps in Breast Surgery: Principles, Techniques and Refinements 
Topics
  • Anatomy and vascular supply of perforator flaps 
  • Types of flap, indications and flap placement 
  • Video presentation: mark-up and US/doppler use 
  • Tips and tricks for chest wall perforator flap 
  • Modifications of LICAP flap
  • Getting started and pitfalls   
Ashutosh Kothari, Peter Barry,
Farid Meybodi, Peter Chin
0900 - 1215
Workshop 4 - Endocrine Deprivation in Breast Cancer Treatment: Managing the Fallout 
Details about this workshop can be found here
Virginia Baird
1215 - 1315Lunch - for Workshop Attendees

1230 - 1315POSTER DISPLAY - AUTHORS PRESENT

1315Conference Opening and Welcome to country

1315 - 1530Session 1 - Hot Topics & Controversies in 2025 
Neoadjuvant systemic therapy and radiotherapy implications 2025 - what is the evidence?
Do anthracyclines still have a place in early breast cancer treatment?  
What the HER2?
Pushing the boundaries of breast conserving surgery  
The patient voice: unmet needs and realities of breast cancer treatment 

Orit Kaidar-Person
Matteo Lambertini
Elena Provenzano
Ashutosh Kothari
Emily Duncan, BCNA Seat at the Table
(SATT) Consumer Representative
1600 - 1745       Session 2 - Wellbeing and Communication
KEYNOTE: When words matter: communicating with the well-informed patient 
Hormone replacement in breast cancer patients: a controversy revisited  
Harnessing AI for Communication Excellence
Lessons, losses and hope: a Medical Oncologist reflects 
Q&A panel                                                                                                                                                                       

Lesley Fallowfield
Rhea Liang
Dawid Naude
Nicholas Wilcken 
1745 - 1945Social Function - Welcome/Networking Event (Exhibition Area)                                                     

Friday 10th October 2025

0715 - 830                    Industry Breakfast Session
Title: Precision Medicine in Breast Cancer: Necessity of Hype?
Speaker: Prof Matteo Lambertini



0715 - 830Industry Breakfast Session
Title: Optimising outcome in oncoplastic and high risk patients
Speaker: Dr Chilton Chong



0845 - 1035Session 3 - Risk Assessment and screening strategies                                                                             
KEYNOTE: Talking about risk & uncertainty in genetic testing 

Next-Gen screening: a look at risk-stratified trials & protocols
Is hormone therapy safe for high-risk women without breast cancer?
Revolutionising BreastScreen: a year of live AI readings in NSW 
The Lancet Breast Cancer Commission - a roadmap for personalising breast cancer  prevention        Q&A panel                                                                                                                                      

Lesley Fallowfield    
Nehmat Houssami                           
Rhea Liang   
Matthew Warner-Smith                       
Kelly Anne Phillips  
                                    
1100 - 1245 Session 4 - The Neoadjuvant multidisciplinary approach to management of breast cancer - the complexities              
Case Study 1 - Timing, sequencing and surgery: a complex case of high-risk breast cancer
Case Study 2 - Young and ER-Positive: navigating the challenges of endocrine therapy intolerance 
The pathological assessment of neoadjuvant treated breast cancer 
Preoperative endocrine therapy as a functional biomarker in ER+ breast cancer 
Q&A panel                 


Tivya Kulasegaran 
Tivya Kulasegaran                            
Elena Provenzano   
Belinda Yeo                     
Matteo Lambertini, Ash Kothari. Elena      Provenzano,  Philip Poortmans, 
Orit Kaidar-Person, Lesley Fallowfield,
Belinda Yeo, Owen Ung, Cameron Snell, Gillian Lamoury 
 
1245 - 1345Lunch in Trade Area
POSTER DISPLAY - AUTHORS PRESENT


1245ASBD AGM

1345 - 1530Session 5  Rapid fire - Abstracts and oral presentations
KEYNOTE:  The young premenopausal woman the issues facing fertility, survivorship, pregnancy and genetic implications

Q & A
4 x 7 minute oral presentations
Q & A
4 x 7 minute oral presentations
Q & A

Matteo Lambertini
1600 - 1730Session 6 - Innovation and Advances
KEYNOTE: AI, Digital Biomarkers - integration of AI into breast cancer pathology

Smarter Surgery: Strategies to lower re-excision rates
Innovations in Imaging: The PET trial and next-generation PET modalities 
The therapeutic value of mainstream genetic testing 
Q&A panel

Elena Provenzano
Ashutosh Kothari
Remy Lim
Annabel Goodwin 
1900 - 2300Conference Dinner - QT Hotel

Sponsored by

 



Saturday 11th October 2025


0715 - 830          Industry Breakfast Session  
Title: Putting Patients First: Multidisciplinary Strategies for Managing Adverse Events in
Patients Treated with KEYTRUDA® (pembrolizumab) in High-Risk Early Stage TNBC                  

                                                                                                                               

0715 - 830                                                                                    
Industry Breakfast Session
Title: Bridging the Gap: A Multidisciplinary Morning on Regional and Remote Challenges in Breast Care 

Description: Join Siemens Healthineers for an engaging breakfast panel discussion bringing together leading experts from across the breast care continuum - including breast imaging, surgery, and radiation oncology - to explore the current landscape of breast disease management in Australia and New Zealand.

 This multidisciplinary panel will explore the unique challenges faced by patients and clinicians in remote and regional communities, along with emerging trends and technologies in breast care that have the potential to bridge the access gap and promote greater equity for everyone, everywhere, sustainably.  From disparities in access to leading technologies and workforce shortages, to diagnostic delays and infrastructure gaps, our panelists will share insights from the front lines and offer practical strategies to drive equitable outcomes across the healthcare system.

 This session promises thought-provoking discussion, cross-disciplinary perspectives, and a collaborative environment - over breakfast. Whether you're a clinician, policy maker, department administrator or healthcare innovator, this event offers a valuable opportunity to be part of the conversation shaping the future of breast care in our most underserved regions.



0845 - 1030Session 7 - Concurrent Sessions

7A Surgery and Radiotherapy  - Updates in Management                                                                                     
Global trends in training and practice of Oncoplastic Breast Surgery
Sentinel Node Mapping: options beyond Tc99
TAD talk: a practical review of Axillary De-escalation
Debate: Management of residual nodal disease after NACT                                               
Q&A panel  
                                                                                                                                             
                                                                                                                                                          

7B Medical Oncology - Estrogen receptor positive disease                                                              

De-escalation in early HER2+ and TNBC: opportunities for tailored treatment 
HER2 is only half the story: the critical role of ER in HER2+ breast cancer 
What's next? Evolving treatment strategies after CDK4/6 inhibition progression                       
All CLEAR - a strategy aiming at zero deaths from breast cancer
Redefining phase 1: a first step, not a final hope                                                                                          
Q&A panel                                                                                                                                                                                                                              



Ashutosh Kothari
Peter Barry
Farid Meybodi
For further surgery: Ashutosh Kothari 
For radiotherapy: Orit Kaidar-Person                                                                                                                                                                                        Belinda Yeo
Nicholas Wilcken 
Matteo Lambertini
Christine Chaffer
Dhanusha Sabanathan
1100 - 1245Session 8 - Survivorship 
KEYNOTE: Key learnings from a  real-world survivorship clinic

Managing long term toxicities - bone matters
Managing long term toxicities - heart matters 
Lymphoedema & Musculoskeletal issues update
Nutrition, diets and supplements - navigating the plethora of information
Q&A panel                                                                                                                                                                    

Kim Kerin-Ayres
Mike Lin
Matthew Burrage
Robyn Box
Rewa Keegan
1245 - 1330
Lunch in Trade Area
POSTER DISPLAY - AUTHORS PRESENT

1330 - 1500Session 9 - The last word on controversies panel                                                                                    
Are we overtreating the low-risk cancer? 
High breast density: what now?
Fibroepithelial lesions and predicting behaviour
Radiotherapy to implant reconstruction and after skin sparing mastectomy
Last chance questions - ask before it's too late!                                                                                           

Philip Poortmans
Nehmat Houssami
Sandra O'Toole
Orit Kaidar-Person
1515Conference Close                                                                                                                                                   Peter Chin & Maree Colosimo

*Times are subject to change 

CONTACT US


Impact Events ABN 45 094 598 339 
Address: Unit 24, Level 3, 2 Brandon Park Drive, Wheelers Hill  Victoria 3150 Australia
Phone: 1300 061 814 or +61 3 8657 4987 Email: info@impactevents.com.au